Events

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

Attend the 2022 PDA Rapid Microbiological Methods Workshop to gain meaningful insight and practical lessons learned from actual success stories on important issues currently facing the industry.

The global bioprocessing summit has emerged as a leading forum for process development, analytical and formulation scientists, and industry experts to share day-to-day challenges and practical solutions for the development, manufacture, and quality of antibodies, vaccines, and gene therapies.

The scientific program will feature a wide range of topics to highlight how interdisciplinary research has enabled us to push boundaries in our understanding of craniofacial research, including talks investigating the physics and mechanics of craniofacial development and regeneration.

This meeting convenes world-leading experts across disease research and biotechnology to present the latest in stem cell science and therapeutic discovery.

The 3rd Annual Gene Therapy Immunogenicity Summit is a forum enabling you to better modulate, measure, and predict the immune response to your gene therapy candidate.

Dr. Peter Dahlberg, Stanford/SLAC

Our 2022 Annual Joint Meeting will be held on October 31 - November 2 in Ann Arbor, MI.

With knowledge-sharing & innovation in the manufacturing, regulation and commercialization of advanced therapies more critical than ever, hear from cell & gene therapy leaders targeting increasingly difficult disease areas.

The International Society for Stem Cell Research (ISSCR) invites you to join us for the 2022 Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success” which will take place at the, Boston Marriott Cambridge Boston, MA from November 17-19, 2022.

The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies.

DMC is the nation’s annual forum for enhancing and leveraging the efforts of engineers, managers, technology leaders, scientists, and policymakers across the defense manufacturing industrial base. Leaders and manufacturing subject matter experts from government, industry, and academia exchange information and perspectives on defense manufacturing policies, strategic direction, best practices, funding opportunities, and the latest manufacturing innovations that will benefit our warfighters.

World renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs.

Dr. David Pagliarini, Washington University in St. Louis